Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_assertion description "[The COX pathway has been a target for pharmaceutical intervention in diseases with a high inflammatory component ranging from asthma and Alzheimer's to arthritis and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_assertion evidence source_evidence_literature NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_assertion SIO_000772 19390242 NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_assertion wasDerivedFrom befree-20140225 NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_assertion wasGeneratedBy ECO_0000203 NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.
- befree-20140225 importedOn "2014-02-25" NP493041.RAvA0yaX21KtQZeKXU7OIDXZ-o-VyPHdYq1zF5uAH2J_g130_provenance.